Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...
Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...
The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...
The US Environmental Protection Agency (EPA) disclosed Monday that it banned nearly all uses of trichloroethylene (TCE) — an ...
Researchers have suspected for some time that the link between our gut and brain plays a role in the development of Parkinson ...
AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...
AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...
Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 4, 2024 — A ...
Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...
Simple external cues, such as lines on the floor, can help Parkinson’s patients focus their efforts and overcome the ...
SAN ANTONIO - A group of San Antonians with Parkinson's Disease are getting their voices back thanks to a rehab program through University Health that's pumping ...